ABTI Stock Overview
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Alterola Biotech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0037 |
| 52 Week High | US$0.041 |
| 52 Week Low | US$0.0012 |
| Beta | -0.099 |
| 1 Month Change | 15.63% |
| 3 Month Change | -15.91% |
| 1 Year Change | -89.12% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| ABTI | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | -0.7% |
| 1Y | -89.1% | 11.6% | 22.3% |
Return vs Industry: ABTI underperformed the US Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: ABTI underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| ABTI volatility | |
|---|---|
| ABTI Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ABTI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ABTI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | David Hitchcock | www.alterolabio.com |
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. was founded in 2021 and is based in Birkenhead, the United Kingdom.
Alterola Biotech, Inc. Fundamentals Summary
| ABTI fundamental statistics | |
|---|---|
| Market cap | US$5.12m |
| Earnings (TTM) | -US$2.88m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.8x
P/E RatioIs ABTI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABTI income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.88m |
| Earnings | -US$2.88m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0021 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -18.0% |
How did ABTI perform over the long term?
See historical performance and comparison